296 related articles for article (PubMed ID: 30179845)
21. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
22. Umbelliferone Ameliorates Benign Prostatic Hyperplasia by Inhibiting Cell Proliferation and G1/S Phase Cell Cycle Progression through Regulation of STAT3/E2F1 Axis.
Kim HJ; Jin BR; An HJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445725
[TBL] [Abstract][Full Text] [Related]
23. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
[TBL] [Abstract][Full Text] [Related]
24. Purple rice extract inhibits testosterone-induced rat prostatic hyperplasia and growth of human prostate cancer cell line by reduction of androgen receptor activation.
Kiriya C; Yeewa R; Khanaree C; Chewonarin T
J Food Biochem; 2019 Sep; 43(9):e12987. PubMed ID: 31489669
[TBL] [Abstract][Full Text] [Related]
25. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
26. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
27. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
28. Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
Jin BR; Kim HJ; Na JH; Lee WK; An HJ
J Adv Res; 2024 Mar; 57():135-147. PubMed ID: 37061215
[TBL] [Abstract][Full Text] [Related]
29. LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Halmos G; Perez R; Fernandez JB; Vidaurre I; Szalontay L
Prostate; 2011 May; 71(7):736-47. PubMed ID: 20945403
[TBL] [Abstract][Full Text] [Related]
30. Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1alpha.
Li SH; Ryu JH; Park SE; Cho YS; Park JW; Lee WJ; Chun YS
J Nutr Biochem; 2010 Sep; 21(9):801-8. PubMed ID: 19716283
[TBL] [Abstract][Full Text] [Related]
31. Potential ameliorative effects of epigallocatechin-3-gallate against cigarette smoke exposure induced renal and hepatic deficits.
Chen J; Liu J; Lei Y; Liu M
Ecotoxicol Environ Saf; 2020 Mar; 191():110202. PubMed ID: 31945511
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
[TBL] [Abstract][Full Text] [Related]
33. Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia.
Quintero-García M; Delgado-González E; Sánchez-Tusie A; Vázquez M; Aceves C; Anguiano B
Free Radic Biol Med; 2018 Feb; 115():298-308. PubMed ID: 29248723
[TBL] [Abstract][Full Text] [Related]
34. VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR‑192, a Smad3-dependent microRNA.
Hong JP; Li XM; Li MX; Zheng FL
Int J Mol Med; 2013 Jun; 31(6):1436-42. PubMed ID: 23588932
[TBL] [Abstract][Full Text] [Related]
35. Leptin promotes epithelial-mesenchymal transition in benign prostatic hyperplasia through downregulation of BAMBI.
Zhang B; Chen X; Xie C; Chen Z; Liu Y; Ru F; He Y
Exp Cell Res; 2020 Feb; 387(1):111754. PubMed ID: 31805276
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.
Zhang YQ; Liu YJ; Mao YF; Dong WW; Zhu XY; Jiang L
Clin Nutr; 2015 Aug; 34(4):752-60. PubMed ID: 25234611
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.
Elbaz EM; Amin HAA; Kamel AS; Ibrahim SM; Helmy HS
Inflammopharmacology; 2020 Oct; 28(5):1407-1420. PubMed ID: 32785828
[TBL] [Abstract][Full Text] [Related]
38. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
Wu SF; Sun HZ; Qi XD; Tu ZH
Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
[TBL] [Abstract][Full Text] [Related]
39. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
[TBL] [Abstract][Full Text] [Related]
40. Neferine attenuates development of testosterone-induced benign prostatic hyperplasia in mice by regulating androgen and TGF-β/Smad signaling pathways.
Liu CM; Shao Z; Chen X; Chen H; Su M; Zhang Z; Wu Z; Zhang P; An L; Jiang Y; Ouyang AJ
Saudi Pharm J; 2023 Jul; 31(7):1219-1228. PubMed ID: 37293563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
